Sunday 19 May 2019

CorkHi10°| Lo

Cork Independent

Business & Professional

Agilent opens extensions of R&D facility

Wednesday, 21st November, 2018 3:54pm

Following the purchase of a Cork biotech start-up, a major US company officially opened a new, purpose-built research and development extension to its Little Island facility.

Agilent Technologies Ireland Ltd recently acquired Cork company Luxcel Biosciences. Agilent described the opening of the state-of-the-art research facility as a “landmark moment for Agilent Ireland as it integrates” with Luxcel Biosciences.

Housing both cell analysis and biosensor development capabilities, this expands Agilent’s reach within the rapidly growing live-cell analysis market and will also further new and innovative technology advancements that will help drive cutting-edge product development for Agilent globally.

“Technology advancements allowing researchers to examine cell health and function kinetically, and in real-time, are driving global demand for complete cell analysis solutions,” said Todd Christian, general manager, Agilent Cell Analysis Division.

“The Luxcel acquisition underscores Agilent’s continued commitment to the cell analysis market and is an important step in expanding our leadership in this field.”

“This exciting acquisition significantly enhances our goal of providing broader solutions to our customers in Ireland and beyond,” said Eddie Enright, country general manager, Agilent Ireland.

“There is a strong cultural fit of innovation and delivering customer-centric solutions between both companies. We are delighted to welcome Luxcel into the Agilent Ireland team.”

The recent open day highlighted future developments and investments within Agilent, while academic and industry experts showcased the importance of partnerships, and knowledge transfer required to develop and deliver reliable laboratory solutions and workflows, particularly in the life science environment. The morning culminated in a tour of the new facilities.

Agilent welcomed David Stanton, Minister of State at the Department of Justice and Equality in Ireland. Key members from local authority and educational institutions also attended, as well as business representatives from technology and science, and medical/technology organizations.

Officially opening the extension of the facility, Minister of State David Stanton said: “Cork has a well-established life sciences cluster and Agilent Ireland’s research facility further strengthens this. I would like to congratulate the team and wish the company continued success.”

“We’re excited that Agilent has invested in Ireland,” said Martin Shanahan, chief executive officer, IDA Ireland. “Luxcel has partnerships and active research programs in Ireland, and with major EU and UK research institutions. This expansion will not only provide the most up-to-date and advanced solutions for Agilent’s customers but will also have a significant positive impact within the Irish and European innovation ecosystem.”

“This expansion reflects the scale of Agilent’s engagement to both internally-driven product development, as well as external collaborations, creating an environment for transformational innovation that is exciting to be a part of and contribute to,” said Richard Fernandes, founder, and chief executive officer, Luxcel Biosciences.

Agilent Technologies Inc. operates in life sciences, diagnostics, and applied chemical markets and employs 14,500 people worldwide.

ePaper Service

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8
Desktop, Tablet & Smartphone friendly
Cookies on Cork Independent website
We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the Cork Independent website. However, if you would like to, you can change your cookie settings at any time by amending your browser settings.
How does Cork Independent use cookies?
Cookies enable us to identify your device, or you when you have logged in. We use cookies that are strictly necessary to enable you to move around the site or to provide certain basic features. We use cookies to enhance the functionality of the website by storing your preferences, for example. We also use cookies to help us to improve the performance of our website to provide you with a better user experience.
We don't sell the information collected by cookies, nor do we disclose the information to third parties, except where required by law (for example to government bodies and law enforcement agencies).
Hide Message